Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENZALUTAMIDE vs EPCORITAMAB-BYSP: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ENZALUTAMIDE vs EPCORITAMAB-BYSP: Safety Overview

Metric ENZALUTAMIDE EPCORITAMAB-BYSP
Total FAERS Reports 49,270 978
Deaths Reported 9,676 341
Death Rate 19.6% 34.9%
Hospitalizations 9,282 199
Average Patient Age 76.0 yrs 71.6 yrs
% Female Patients 0.6% 41.6%
FDA Approval Date Apr 22, 2022 N/A
Manufacturer Astellas Pharma US, Inc. N/A
Route ORAL N/A
Marketing Status Prescription Prescription